tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Mainwaring, 5 are a BUY (62.5%), 3 are a HOLD (37.5%).
Analyst James Mainwaring, currently employed at ATLANTIC EQUITIES, carries an average stock price target met ratio of 58.33% that have a potential upside of 11.22% achieved within 274 days.
James Mainwaring’s has documented 14 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDT, Medtronic PLC at 01-Jun-2022.
Analyst best performing recommendations are on A (AGILENT TECHNOLOGIES).
The best stock recommendation documented was for A (AGILENT TECHNOLOGIES) at 4/12/2022. The price target of $135 was fulfilled within 127 days with a profit of $12.97 (10.63%) receiving and performance score of 0.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Jul-2026
$135
$0.71 (0.53%)
$180
2 days ago
(09-Jul-2026)
7/10 (70%)
$1.41 (1.06%)
271
Buy Since 06-Apr-2026
$148
$13.71 (10.21%)
$140
5 days ago
(06-Jul-2026)
7/10 (70%)
$17.4 (13.32%)
27
Buy Since 26-Feb-2026
$150
$13.99 (10.29%)
$145
17 days ago
(24-Jun-2026)
16/22 (72.73%)
$18.37 (13.96%)
122
Buy Since 02-Jun-2026
$155
$18.99 (13.96%)
$145
1 months 9 days ago
(02-Jun-2026)
9/13 (69.23%)
$19.95 (14.77%)
164
Buy Since 24-May-2023
$155
$18.99 (13.96%)
$165
1 months 13 days ago
(28-May-2026)
15/20 (75%)
$19.62 (14.49%)
249
What Year was the first public recommendation made by James Mainwaring?
